Ziprasidone: Oral bioavailability doubles when taken with food; dosing on an empty stomach delivers only ~36% of the intended exposure, leading users to redose unnecessarily. Therapeutic QTc prolongation averages 10-20 msec, but heavy recreational doses (>160 mg/day) or IV diversion markedly increas
Related pages